GNTA
Genenta Science SpA ADRNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$16.33M
P/E Ratio
—
EPS
$-0.39
Beta
0.73
52W High
$6.20
52W Low
$0.59
50-Day MA
$0.77
200-Day MA
$2.04
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Genenta Science SpA ADR
Genenta Science SpA, a clinical-stage biotechnology company, is dedicated to the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company is headquartered in Milan, Italy.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-6.58M |
| Operating Margin | 0.00% |
| Return on Equity | -38.00% |
| Return on Assets | -17.70% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.09 |
| Price-to-Book | 0.67 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -11.48 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $23.59M |
| Float | $17.92M |
| % Insiders | 30.38% |
| % Institutions | 14.15% |
Historical Volatility
HV 10-Day
47.54%
HV 20-Day
58.75%
HV 30-Day
89.70%
HV 60-Day
88.99%
HV Rank
—
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 5/5/2026